How bladder sensations during filling relate to overactive bladder in people with multiple sclerosis
Official title: Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
Run by Assistance Publique - Hôpitaux de Paris · NCT05772637 · Data updated 2026-11-12
We will test whether changes in bladder sensations during filling are linked to overactive bladder symptoms in adults with multiple sclerosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 113 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris, Choisir Une Région) |
| Status | Recruiting |
| Started | February 14, 2024 |
| Main results expected | February 14, 2027 |
| Study ends | February 14, 2027 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT05772637 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with MS diagnosed by 2017 McDonald criteria who have bladder symptoms related to MS, are not currently on bladder medications, can read and write French, have required social security coverage, and have an indication for urodynamics are ideal candidates.
✕Probably not a fit
Patients with recent MS relapse, other neurological diseases, pregnancy or breastfeeding, recent bladder treatments or surgery, legal protection status, or those unable to use the analog sensation device are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional protocol uses repeated cystometries (urodynamic tests) while recording patients' reported bladder sensations at key filling points, and may include bladder diaries to capture sensation intensity. Participants are adults with multiple sclerosis and bladder symptoms who are not currently taking bladder medications and can undergo urodynamic testing. The goal is to correlate sensation patterns (increased, decreased, or normal) with the severity of overactive bladder symptoms and to distinguish sensation-driven problems from detrusor overactivity. People with recent MS relapse, other neurological disease, pregnancy, recent bladder treatments, or inability to use the sensation-recording device are excluded.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify when abnormal bladder sensation—not only muscle overactivity—is driving overactive bladder symptoms, allowing more targeted management.
How similar studies have gone: Previous urodynamic work has well described detrusor overactivity, but systematic tracking of bladder sensations during cystometry is relatively novel and not well characterized in MS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 * MS according to the 2017 Mac Donald diagnostic criteria * Bladder disorders supposedly related to MS * Indication to perform urodynamics * No current medication for bladder disorders * Able to understand and right in French * Affiliated to the "Securite sociale" or "Couverture Medicale Universelle (CMU)", or equivalent organism. Exclusion criteria: * Legal protection * Pregnancy or breastfeeding mother * MS relapse during the past month * Other associated neurological disease * Genuine stress incontinence related to postpartum * Treatment with antimuscarinics, alpha blockers, beta3 adrenergic, or tibial nerve stimulation in the past 15 days, or with botulinic toxin injection in the past 6 months * Previous lower urinary tract surgery * Inability to use the analogic device due to motor, sensory or ataxic disabilities
Where it's running
-
Hôpital TENON
Paris, Choisir Une Région, France Recruiting
Study contacts
- Study coordinator: Claire Hentzen, MD
- Email: claire.hentzen@aphp.fr
- Phone: 0156017500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer
This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.
-
Self-Start Macrobid for post-Botox lower urinary symptoms
This study tests whether giving a standing prescription for Macrobid after Botox treatment reduces urgent calls, messages, and visits for urinary symptoms compared with usual triage care.
-
ZIDA Control Sock added to medication for overactive bladder with leakage
This trial will try using the ZIDA Control Sock once a week at home for 12 weeks to see if adding it to your current medication reduces urgency urinary incontinence.
-
Vaginal radiofrequency treatment targeting bladder nerves for overactive bladder in women
This trial will test whether a single vaginal radiofrequency treatment with the MORPHEUSV device can reduce urgency-related urine leaks in adult women with overactive bladder.
-
Tensi+ European registry for overactive bladder
This registry will collect information on adults with overactive bladder who use the Tensi+ posterior tibial nerve stimulation device to see if it helps symptoms and is safe over one year.
-
Sexual problems in women with relapsing-remitting multiple sclerosis
See if sexual dysfunction is common in women aged 25-50 with relapsing-remitting MS and whether it's linked to fatigue, mood, bladder symptoms, and cognitive problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.